TScan Therapeutics, Inc.
TCRX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$36 | -$37 | -$34 | -$36 |
| Dep. & Amort. | $1 | $1 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $3 | $3 | $3 |
| Change in WC | -$0 | $0 | -$6 | $5 |
| Other Non-Cash | $3 | -$1 | -$1 | -$0 |
| Operating Cash Flow | -$32 | -$33 | -$38 | -$27 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$1 | -$2 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$27 | -$61 | -$47 |
| Inv. Sales/Matur. | $34 | $76 | $76 | $76 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $33 | $48 | $14 | $27 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $15 |
| Stock Issued | $0 | $0 | $0 | $30 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$0 | -$1 | $0 |
| Financing Cash Flow | $0 | $0 | -$1 | $46 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $0 | $15 | -$25 | $46 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $169 | $159 | $184 | $138 |
| End Cash | $170 | $174 | $159 | $184 |
| Free Cash Flow | -$34 | -$35 | -$39 | -$28 |